In a statement to Gothamist , a city spokesperson admitted that municipal employee insurance coverage for these fullness-mimicking medicines was made in error. The city never planned to cover these drugs, spokesperson Liz Garcia told the website, due to the steep costs that would fall on city employees. While those who take GLP-1s for diabetes will continue to have their medication covered by municipal insurer EmblemHealth, those who use them strictly for weight loss will be left out in the cold
As healthcare professionals and patients work together to navigate the transition to this groundbreaking medication, the potential for improved outcomes and enhanced quality of life is truly exciting
Wang, H., Li, T., Chen, S., Gu, Y
Oral semaglutide works by activating GLP-1 receptors in the brain, reducing hunger, and promoting a sense of fullness, while also slowing gastric emptying to prolong satiety
These exclusions ensured accurate determinations of baseline parameters